Cargando…
Feprazone Displays Antiadipogenesis and Antiobesity Capacities in in Vitro 3 T3-L1 Cells and in Vivo Mice
[Image: see text] Background and purpose: Excessive lipid accumulation in adipose tissues and deregulation of adipogenesis-induced obesity affect millions of people worldwide. Feprazone, a nonsteroidal anti-inflammatory drug, has a wide clinical use. However, it is unknown whether Feprazone possesse...
Autores principales: | Che, Liqun, Ren, Bo, Jia, Yuanyuan, Dong, Yujia, Wang, Yanbing, Shan, Jie, Wang, Yuchun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2021
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7970497/ https://www.ncbi.nlm.nih.gov/pubmed/33748580 http://dx.doi.org/10.1021/acsomega.0c05470 |
Ejemplares similares
-
Antiadipogenesis of Oroxylum indicum (L.) Kurz Extract via PPARγ2 in 3T3-L1 Adipocytes
por: Hengpratom, Tanaporn, et al.
Publicado: (2020) -
Feprazone Mitigates IL-1β-Induced Cellular Senescence
in Chondrocytes
por: Huang, Zhusong, et al.
Publicado: (2021) -
Correction to “Feprazone Mitigates IL-1β-Induced
Cellular Senescence in Chondrocytes”
por: Huang, Zhusong, et al.
Publicado: (2022) -
Antiobesity and Antioxidative Effect of Fermented Brown Rice Using In Vitro with In Vivo Caenorhabditis elegans Model
por: Barathikannan, Kaliyan, et al.
Publicado: (2023) -
Antiobesity and antihyperglycaemic effects of Adiantum capillus-veneris extracts: in vitro and in vivo evaluations
por: Kasabri, Violet, et al.
Publicado: (2016)